The emerging mechanisms of isoform-specific PI3K signalling
Top Cited Papers
- 9 April 2010
- journal article
- review article
- Published by Springer Nature in Nature Reviews Molecular Cell Biology
- Vol. 11 (5) , 329-341
Abstract
Phosphoinositide 3-kinases (PI3Ks) function early in intracellular signal transduction pathways and affect many biological functions. A further level of complexity derives from the existence of eight PI3K isoforms, which are divided into class I, class II and class III PI3Ks. PI3K signalling has been implicated in metabolic control, immunity, angiogenesis and cardiovascular homeostasis, and is one of the most frequently deregulated pathways in cancer. PI3K inhibitors have recently entered clinical trials in oncology. A better understanding of how the different PI3K isoforms are regulated and control signalling could uncover their roles in pathology and reveal in which disease contexts their blockade could be most beneficial.Keywords
This publication has 182 references indexed in Scilit:
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K ActivationCancer Cell, 2009
- Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K SignalingCancer Cell, 2009
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human CancerCancer Cell, 2009
- Structure and Function of Vps15 in the Endosomal G Protein Signaling Pathway,Biochemistry, 2009
- Functional differences between two classes of oncogenic mutation in the PIK3CA geneBiochemical and Biophysical Research Communications, 2009
- Tenets of PTEN Tumor SuppressionCell, 2008
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Membrane binding domainsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- Probing phosphoinositide functions in signaling and membrane traffickingTrends in Cell Biology, 2005